IRAD2 : Patients With Respiratory Failure at Home
Chronic Respiratory Failure, Nutritional Depletion
About this trial
This is an interventional treatment trial for Chronic Respiratory Failure focused on measuring Chronic Respiratory Failure, Pulmonary Rehabilitation, Nutritional Depletion, Home, COPD, Oral Dietary Supplements, Therapeutic Education, Androgens, Exacerbation, Survival
Eligibility Criteria
Inclusion Criteria: well informed and consenting person woman is old enough to procreate Assisted respiratory treatment at home for 3 months : oxygenotherapy > 8 hours per day and/or assisted ventilation > 6 hours per day. PaO2 without oxygenotherapy ≤ 8 kPa or 60 mmHg on ambient air at the beginning of assisted respiratory treatment. Affection : chronic obstructive bronchopneumopathy, diffuse bronchial dilatation, non neuromuscular restrictive syndrome (pulmonary diffuse infiltration, parietal lesion) obstructive and restrictive syndrome. malnourished person, one of following criteria :Body Mass Index ≤ 21kg/m2 or weight loss (10% of the previous weight) or non-fatty mass measured by 50 Hz impedancemetry ≤25th percentiles or ≤ 63% of ideal weight for women, ≤ 67% of ideal weight for men. Exclusion Criteria: Sleep apnea with daytime drowsiness (drowsiness scale of Epworth > 9/24) Known pathology that reduce the vital prognosis at 6 months (AIDS, cancer...). History of hormone dependent cancer ( breast cancer, prostate cancer), pathologic Prostate Specific Antigen. Inability to follow a rehabilitation program
Sites / Locations
- University Hospital Dominique Larrey
- Rehabilitation Department of Cyr Voisin
- University Hospital Arnaud de Villeneuve
- Hospital la Pitiè-Salpétrière
- University Hospital of Poitiers
- University Hospital Bois Guillaume
- North University Hospital of St Etienne
- Departement of Medicine, University Hospital of Genève